Stable Angina clinical trials at UCSF
2 research studies open to eligible people
Stable angina is chest discomfort from reduced blood flow to the heart. UCSF is testing a small implant in a heart vein for patients whose pain does not ease with medicines. UCSF is also comparing in-person and telehealth cardiac rehab programs with exercise and education.
COronary SInus Reducer in Patients With Refractory Angina II
open to eligible people ages 18 years and up
To demonstrate the safety and effectiveness of the Shockwave Reducer for treatment of patients with refractory angina pectoris treated with maximally tolerated guideline-directed medical therapy who demonstrate objective evidence of reversible myocardial ischemia in the distribution of the left coronary artery and who are deemed unsuitable for revascularization. A non-randomized single-arm registry will further assess the safety and effectiveness of the Shockwave Reducer in selected subjects with reversible myocardial ischemia in the distribution of the right coronary artery and who are deemed unsuitable for revascularization, subjects without documented obstructive coronary disease and abnormal coronary flow reserve (ANOCA), and subjects who cannot complete an exercise tolerance test due to lower limb amputation (above the ankle) or other physiologic condition with documented chronic mobility or balance issues that require the use of a walking aid.
San Francisco, California and other locations
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
open to eligible people ages 18 years and up
Cardiac rehabilitation is a medically recommended program for patients with certain heart conditions. It includes exercise training, health education, and counseling. Unfortunately, many patients do not participate in cardiac rehabilitation. Some find it challenging to attend the in-person sessions. This study aims to compare two methods of delivering cardiac rehabilitation: in-person and through telehealth. The investigators want to know if the effects of these two programs are alike and if certain individuals benefit more from one program over the other.
San Francisco, California and other locations
Our lead scientists for Stable Angina research studies include Alexis Beatty, MD, MAS Yousif Ahmad.
Last updated: